VC-backed IPO profiles from September 2015

IPO Profile: Regenxbio Inc Company Details Rockville, Md. 240-552-8181 Description: REGENXBIO Inc, formerly ReGenX Biosciences, LLC, is a biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. The company’s AAV gene delivery ...

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.